• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Long-standing otitis media with effusion--a convenient model for the study of antibiotic penetration to respiratory tract secretions.

作者信息

Edén T

出版信息

Scand J Infect Dis Suppl. 1985;44:46-51.

PMID:3860937
Abstract

In long-standing otitis media with effusion, myringotomy with aspiration of the middle ear exsudate is an established therapeutical procedure, which can be performed under carefully planned conditions. This common disease thus offers convenient advantages for the study of antibiotic concentrations in the middle ear. This is exemplified by a review of studies with erythromycin, doxycycline and cefaclor. A delayed penetration into the middle ear was demonstrated for all these antibiotics, especially for erythromycin. The elimination from the middle ear was slower than from serum, at least with erythromycin and doxycycline. With these two antibiotics, the middle ear concentrations were close to the peak serum levels, with only small fluctuations between doses during a course of treatment. With cefaclor, peak middle ear concentrations were less than 40% of peak serum levels. By using this model, data from a natural disease in humans are obtained. Since the mucosa anywhere in the respiratory tract reacts in a uniform manner to an inflammatory stimulus, results from studies on long-standing otitis media with effusion can disclose some aspects on antibiotic pharmacokinetics in respiratory tract secretions in general.

摘要

相似文献

1
Long-standing otitis media with effusion--a convenient model for the study of antibiotic penetration to respiratory tract secretions.
Scand J Infect Dis Suppl. 1985;44:46-51.
2
Penetration of cefaclor to adenoid tissue and middle ear fluid in secretory otitis media.
Scand J Infect Dis Suppl. 1983;39:48-52.
3
Penetration of erythromycin through respiratory mucosa. A study using secretory otitis media as a model.红霉素透过呼吸道黏膜的情况。一项以分泌性中耳炎为模型的研究。
Acta Otolaryngol Suppl. 1979;365:1-17. doi: 10.3109/00016487909124940.
4
Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media.阿莫西林、头孢克洛、红霉素 - 磺胺异恶唑及甲氧苄啶 - 磺胺甲恶唑在慢性浆液性中耳炎患者中耳液中的渗透情况。
J Infect Dis. 1982 Jun;145(6):815-21. doi: 10.1093/infdis/145.6.815.
5
Compositional difference in middle ear effusion: mucous versus serous.中耳积液的成分差异:黏液性与浆液性。
Laryngoscope. 2002 Jan;112(1):152-5. doi: 10.1097/00005537-200201000-00027.
6
Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.小儿分泌性中耳炎中鼻咽呼吸黏膜MUC5AC和MUC5B黏蛋白基因上调以及中耳MUC5B选择性上调。
Laryngoscope. 2006 Mar;116(3):365-9. doi: 10.1097/01.MLG.0000195290.71090.A1.
7
Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion.阿莫西林克拉维酸钾与头孢克洛治疗急性分泌性中耳炎的对比治疗试验。
Pediatrics. 1985 May;75(5):819-26.
8
Penetration of doxycycline in respiratory mucosa.强力霉素在呼吸道黏膜中的渗透情况。
Acta Otolaryngol. 1983 Nov-Dec;96(5-6):501-8. doi: 10.3109/00016488309132737.
9
[Expressions of fibronectin and laminin in the middle ear mucosa with experimental middle ear effusions: immunohistochemical study].[实验性中耳积液时中耳黏膜中纤连蛋白和层粘连蛋白的表达:免疫组织化学研究]
Zhonghua Er Bi Yan Hou Ke Za Zhi. 1998 Jun;33(3):172-4.
10
[Pharmacokinetic study of antibiotics in otitis].[抗生素在中耳炎中的药代动力学研究]
Ann Otolaryngol Chir Cervicofac. 1993;110(7):393-8.

引用本文的文献

1
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.抗感染药物的药代动力学和药效学问题:杀菌曲线与最低抑菌浓度
Antimicrob Agents Chemother. 2004 Feb;48(2):369-77. doi: 10.1128/AAC.48.2.369-377.2004.